CVS Health Corporation $CVS Holdings Lowered by APG Asset Management N.V.

APG Asset Management N.V. lowered its stake in CVS Health Corporation (NYSE:CVS) by 6.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 773,455 shares of the pharmacy operator’s stock after selling 50,592 shares during the quarter. APG Asset Management N.V. owned approximately 0.06% of CVS Health worth $58,311,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in CVS. Y Intercept Hong Kong Ltd acquired a new stake in CVS Health during the 2nd quarter valued at $1,228,000. Savvy Advisors Inc. raised its position in CVS Health by 57.3% during the second quarter. Savvy Advisors Inc. now owns 5,493 shares of the pharmacy operator’s stock valued at $379,000 after buying an additional 2,001 shares during the period. Atria Investments Inc lifted its stake in CVS Health by 7.0% in the 2nd quarter. Atria Investments Inc now owns 73,684 shares of the pharmacy operator’s stock worth $5,083,000 after acquiring an additional 4,795 shares in the last quarter. AlphaStar Capital Management LLC acquired a new stake in CVS Health during the 2nd quarter worth about $385,000. Finally, GHP Investment Advisors Inc. grew its stake in CVS Health by 11.4% during the 2nd quarter. GHP Investment Advisors Inc. now owns 63,311 shares of the pharmacy operator’s stock valued at $4,367,000 after acquiring an additional 6,476 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Barclays raised their price target on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Royal Bank Of Canada reissued an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. The Goldman Sachs Group increased their price objective on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Finally, JPMorgan Chase & Co. boosted their target price on CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Nineteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Stock Up 2.2%

NYSE CVS opened at $79.74 on Monday. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The stock has a market cap of $101.44 billion, a PE ratio of 57.78, a PEG ratio of 0.83 and a beta of 0.49. The firm has a 50-day simple moving average of $78.39 and a 200 day simple moving average of $77.29. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is presently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.